Director dealings: Optibiotix CEO ups stake
Optibiotix Health revealed on Wednesday that chief executive René Kamminga had purchased 8,188 ordinary shares in the AIM-listed life sciences firm.
FTSE AIM All-Share
728.67
15:45 15/11/24
n/a
n/a
OptiBiotix Health
13.50p
13:50 15/11/24
0.00%
0.00p
Pharmaceuticals & Biotechnology
19,259.77
15:45 15/11/24
-2.70%
-535.19
Kamminga, who was named as CEO back in March, purchased the shares on Tuesday at an average price of 55.40p each, for a total value of £4,536.15.
Following the transaction, Kamminga holds an interest in 43,188 ordinary shares in the company, representing 0.05% of Optibiotix's issued share capital.
As of 1615 BST, Optibiotix shares were down 1.52% at 54.56p.
Top Director Buys
Optibiotix Health (OPTI)
Director name: Kamminga,René
Amount purchased: 8,188 @ 55.40p
Value: £4,536.15
Natwest Group Plc Ord 100p (NWG)
Director name: Murray,Katie
Amount purchased: 69 @ 214.96p
Value: £148.32
Top Director Sells